Body mass index, HbA1c and serum C-reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital-based retrospective case-control study.

MLA

Terui, Hitoshi, et al. “Body Mass Index, HbA1c and Serum C-Reactive Protein Are Predictors of Secondary Failure in Infliximab Continuance for Japanese Psoriasis Patients: A Hospital-Based Retrospective Case-Control Study.” The Journal of Dermatology, vol. 48, no. 11, Nov. 2021, pp. 1719–23. EBSCOhost, https://doi.org/10.1111/1346-8138.16096.

APA

Terui, H., Asano, M., Shimada-Omori, R., Tsuchiyama, K., Takahashi, T., Nasu-Tamabuchi, M., Hagiwara-Takita, A., Kusakari, Y., Ohtani, T., Aiba, S., & Yamasaki, K. (2021). Body mass index, HbA1c and serum C-reactive protein are predictors of secondary failure in infliximab continuance for Japanese psoriasis patients: A hospital-based retrospective case-control study. The Journal of Dermatology, 48(11), 1719–1723. https://doi.org/10.1111/1346-8138.16096

Chicago

Terui, Hitoshi, Masayuki Asano, Ryoko Shimada-Omori, Kenichiro Tsuchiyama, Toshiya Takahashi, Mei Nasu-Tamabuchi, Akiko Hagiwara-Takita, et al. 2021. “Body Mass Index, HbA1c and Serum C-Reactive Protein Are Predictors of Secondary Failure in Infliximab Continuance for Japanese Psoriasis Patients: A Hospital-Based Retrospective Case-Control Study.” The Journal of Dermatology 48 (11): 1719–23. doi:10.1111/1346-8138.16096.